CONKLING WILLIAM (Chief Commercial Officer) received a stock award from PROTARA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2026ACC: 0001213900-26-006231
Officer· Chief Commercial Officer
Since Jun 2025
+184K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
184K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+26K
Price / share
—
Trade value
—
% of position
52.0%
1/16/2026
50K→76K
Total
Net shares
+26K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2026 | A · Award | +26K | — | — | 52.0% | 50K | 76K |
| Total | +26K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
158K shares
Shares
+158K
Strike price
5.01
Held after
158K
Exercisable
—
1/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock158K shares | 1/16/2026 | A · Award | +158K | 5.01 | — | 158K |